The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents

NCT07176767 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2025-09-23

No results posted yet for this study

Summary

Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep.

Studying how insomnia affects PAP adherence in children can help improve future treatments.

However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.

Conditions

Interventions

DEVICE

Positive airway pressure therapy

Initiation of continuous or bilevel positive airway pressure therapy

Sponsors & Collaborators

  • American Academy of Sleep Medicine

    collaborator OTHER
  • The Hospital for Sick Children (SickKids)

    collaborator UNKNOWN
  • Lena Xiao

    lead OTHER

Principal Investigators

  • Lena J Xiao, MD, MSc · Provincial Health Services Authority

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-12
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07176767 on ClinicalTrials.gov